Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States.

Sudenga SL, Nyitray AG, Torres BN, Silva R, Villa L, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR
J Infect. 2017 75 (1): 35-47

PMID: 28363585 · PMCID: PMC6640845 · DOI:10.1016/j.jinf.2017.03.010

OBJECTIVES - Globally, anal cancer incidence is rare, but is increasing in some world regions. Our objective was to assess differences in anal HPV natural history in three countries.

METHODS - Men aged 18-70 years were recruited from the US (n = 634), Mexico (n = 665), and Brazil (n = 731). Anal specimens were collected every six-months. HPV genotyping was assessed by Linear Array. Anal HPV prevalence was compared using the Fisher's exact test. HPV infection incidence rates (IR) and 95% confidence intervals (CI) were calculated.

RESULTS - Any anal HPV prevalence was highest among men from Brazil (24%) compared to Mexico (15%) and the US (15%). When stratified by sexual history, the prevalence of any HPV among MSM/MSMW was 43%, 37%, and 45% and 9%, 12%, and 10% for MSW from Brazil, Mexico, and US, respectively. Any HPV incidence was significantly higher among men from Brazil compared to US men (IRR = 2.4, 95% CI = 1.7-3.4) and comparable between men from Mexico and the US (IRR = 1.2, 95% CI = 0.8-1.8).

CONCLUSION - Men in Brazil and Mexico often have similar, if not higher incidence of anal HPV compared to men from the U.S., and may benefit from gender neutral HPV vaccine policies.

Copyright © 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

MeSH Terms (21)

Adolescent Adult Aged Anal Canal Anus Diseases Brazil Heterosexuality HIV Infections Homosexuality, Male Humans Male Mexico Middle Aged Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Prevalence Risk Factors Sexual Behavior United States Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: